ENTITY

XtalPi (2228 HK)

90
Analysis
Health Care • China
XtalPi is a biotechnology company that leverages artificial intelligence, quantum physics, and robotics to provide research and development solutions for early-stage drug discovery and material science. Its services include drug discovery solutions and intelligent automation solutions, offering products like XmartChem and PatSight. The company was founded in 2015 and is headquartered in Shenzhen, China.
more
bullish•MegaRobo Technologies
•26 Jul 2025 01:21

MegaRobo Technologies IPO Valuation Analysis: Headed For $1B+ Public Market Debut In Hong Kong

​MegaRobo Technologies is expected to IPO in third quarter of 2025. In my insight, I discuss IPO valuation, DCF analysis, and key investments risks.

Logo
1.3k Views
Share
bullish•MegaRobo Technologies
•14 Jul 2025 23:41

MegaRobo Technologies IPO Preview: AI-Driven Robotics Unicorn With Strong IP Moat In Automation

​MegaRobo Technologies, AI & robotics unicorn, files for IPO in Hong Kong with strong backing but faces challenges with negative cash flows and...

Logo
1.1k Views
Share
bullish•Kioxia Holdings
•16 Jun 2025 08:08

ECM Weekly (16 June 2025) - Haitian, Sanhua, Kitazato, Primo, Kioxia, Xtalpi, Horizon, Keymed, Wuxi

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
655 Views
Share
bullish•Quantitative Analysis
•15 Jun 2025 10:15

HK Connect Flows Weekly (Jun 13th): BYD, Meituan, CCB, Innovent Biologics, Petrochina, Tencent

We analyzed the Hong Kong Connect Scheme for last week and highlighted flows for BYD, Meituan, CCB, Innovent Biologics, Petrochina, Tencent,...

Logo
929 Views
Share
bearish•XtalPi
•10 Jun 2025 09:48

Xtalpi US$860m IPO Lockup Expiry - Last of the Lockup Release with Nearly All Shares in CCASS Now

XtalPi Holdings (2228 HK) was listed in Hong Kong on 13th Jun 2024 after raising US$126m. Its one-year lockup will expire soon.

Logo
1k Views
Share
x